PMID- 14718643 OWN - NLM STAT- MEDLINE DCOM- 20041019 LR - 20161124 IS - 1096-6080 (Print) IS - 1096-0929 (Linking) VI - 78 IP - 1 DP - 2004 Mar TI - Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). PG - 96-106 AB - Perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes thymic atrophy, but the precise mechanism of such toxicity remains unresolved. The current study investigated the role of apoptosis in TCDD-induced thymic involution following perinatal exposure to TCDD. To this end, C57BL/6 pregnant mice were injected intraperitoneally on gestational day (GD) 14 with a single dose of 10 microg/kg TCDD. Analysis of the thymus on GDs 15, 16, 17, and 18, and on postnatal day (PD) 1, showed a remarkable reduction in thymic cellularity 3-7 days post-TCDD exposure. TCDD treatment also caused marked changes in the proportions of T-cell subsets, particularly on GD 17 and GD 18 thymocytes. In vitro culture of thymocytes from mice exposed perinatally to TCDD showed increased apoptosis when compared to the controls, which peaked on day 3 post-TCDD exposure. Triple-color staining showed that TCDD induced apoptosis in all four subpopulations of T cells, with the double-positive T cells undergoing the highest level. Moreover, increased cleavage of caspase-3 was seen when TCDD-exposed GD 17 thymocytes were directly tested. Furthermore, apoptosis-associated phenotypic changes were found in thymocytes of mice perinatally exposed to TCDD, characterized by an increase in expression of CD3, alphabetaTCR, IL-2R, and CD44, and a decrease in CD4, CD8, and J11d markers. Finally, thymocytes from mice exposed perinatally to TCDD showed higher levels of Fas, TRAIL, and DR5 mRNA, but the levels of Bcl-2, Bcl-xL, and Bax were either unaltered or changed moderately. Taken together, these results suggest that TCDD-induced thymic atrophy following perinatal exposure may result, at least in part, from increased apoptosis mediated by death receptor pathway involving Fas, TRAIL, and DR5. FAU - Camacho, Iris A AU - Camacho IA AD - Department of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298, USA. FAU - Nagarkatti, Mitzi AU - Nagarkatti M FAU - Nagarkatti, Prakash S AU - Nagarkatti PS LA - eng GR - AI 053703/AI/NIAID NIH HHS/United States GR - DA 014885/DA/NIDA NIH HHS/United States GR - DA016545/DA/NIDA NIH HHS/United States GR - ES 09098/ES/NIEHS NIH HHS/United States GR - F31ES11562/ES/NIEHS NIH HHS/United States GR - HL058641/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20040112 PL - United States TA - Toxicol Sci JT - Toxicological sciences : an official journal of the Society of Toxicology JID - 9805461 RN - 0 (DNA Primers) RN - 0 (Polychlorinated Dibenzodioxins) RN - 0 (Teratogens) RN - EC 3.4.22.- (Casp3 protein, mouse) RN - EC 3.4.22.- (Caspase 3) RN - EC 3.4.22.- (Caspases) SB - IM MH - Animals MH - Apoptosis/*drug effects/genetics MH - CD8-Positive T-Lymphocytes/physiology MH - Caspase 3 MH - Caspases/metabolism MH - Cell Separation MH - DNA Primers MH - Female MH - Gene Expression Regulation/drug effects MH - In Situ Nick-End Labeling MH - Mice MH - Mice, Inbred C57BL MH - Phenotype MH - Polychlorinated Dibenzodioxins/*toxicity MH - Pregnancy MH - Reverse Transcriptase Polymerase Chain Reaction MH - Signal Transduction/drug effects MH - T-Lymphocytes/*drug effects MH - Teratogens/*toxicity MH - Thymus Gland/*cytology/*embryology EDAT- 2004/01/14 05:00 MHDA- 2004/10/20 09:00 CRDT- 2004/01/14 05:00 PHST- 2004/01/14 05:00 [pubmed] PHST- 2004/10/20 09:00 [medline] PHST- 2004/01/14 05:00 [entrez] AID - kfh048 [pii] AID - 10.1093/toxsci/kfh048 [doi] PST - ppublish SO - Toxicol Sci. 2004 Mar;78(1):96-106. doi: 10.1093/toxsci/kfh048. Epub 2004 Jan 12.